Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Stocktreeon Oct 05, 2016 5:01pm
99 Views
Post# 25313925

RE:RE:RE:Spectral's Material Charge Report on sedar.com

RE:RE:RE:Spectral's Material Charge Report on sedar.com
Ah, I don't know. Maybe file a complaint to the IIRC. But I don't know much about that.

I will try to avoid commenting further, (other posts) because I do not want to cause harm to anyone's investment.

But I would have assumed (newbie) that top line data should be presented in a standard manner. With all end points detailed with numbers and comments. Not written on the corner of the table one Monday morning. Everything left to wide interpretation. Was there any nuance in the conference presentation as to what the 62% population looked like (80+ year old patients who have been admitted severeal times to the ICU)? Was there any hint that something could go wrong? Then, a few days later, they miss their target by a mile? Sorry for my bad temper.

Ciao Josh

Bullboard Posts